BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 27023012)

  • 1. Long-term Results of Troublesome CWD Cavity Reconstruction by Mastoid and Epitympanic Bony Obliteration (CWR-BOT) in Adults.
    Vercruysse JP; van Dinther JJ; De Foer B; Casselman J; Somers T; Zarowski A; Cremers CC; Offeciers E
    Otol Neurotol; 2016 Jul; 37(6):698-703. PubMed ID: 27023012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
    Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
    Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
    Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
    J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical Treatment for Troublesome Mastoid Cavities: Canal Wall Reconstruction With Bony Obliteration Versus Subtotal Petrosectomy.
    Kemps G; Geven L; Kunst H; Mylanus E; Mulder J; Lanting C; Pennings R
    Otol Neurotol; 2024 Mar; 45(3):273-280. PubMed ID: 38270225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Soft Versus Bony Canal Wall Reconstruction with Mastoid Obliteration.
    Vesole AS; Doyle EJ; Sarkovics K; Gharib M; Samy RN
    Otol Neurotol; 2024 Jun; 45(5):542-548. PubMed ID: 38511274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bony Obliteration Tympanoplasty in Pediatric Cholesteatoma: Long-term Safety and Hygienic Results.
    van Dinther JJ; Vercruysse JP; Camp S; De Foer B; Casselman J; Somers T; Zarowski A; Cremers CW; Offeciers E
    Otol Neurotol; 2015 Sep; 36(9):1504-9. PubMed ID: 26375973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastoid obliteration: autogenous cranial bone pAte reconstruction.
    Roberson JB; Mason TP; Stidham KR
    Otol Neurotol; 2003 Mar; 24(2):132-40. PubMed ID: 12621322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bony obliteration tympanoplasty in cholesteatoma: safety, hygiene and hearing outcome: allograft versus autograft tympanic membrane reconstruction.
    van Waegeningh HF; van Dinther JJS; Vanspauwen R; Zarowski A; Offeciers E
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1805-1813. PubMed ID: 32761272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrograde mastoidectomy with canal wall reconstruction: a follow-up report.
    Dornhoffer JL
    Otol Neurotol; 2004 Sep; 25(5):653-60. PubMed ID: 15353991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
    Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
    Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
    Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
    Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canal wall reconstruction in cholesteatoma surgeries: rate of residual.
    Roux A; Bakhos D; Lescanne E; Cottier JP; Robier A
    Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2791-7. PubMed ID: 25227760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
    Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
    Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of canal wall reconstruction tympanomastoidectomy.
    Walker PC; Mowry SE; Hansen MR; Gantz BJ
    Otol Neurotol; 2014 Jul; 35(6):954-60. PubMed ID: 25072070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of canal wall reconstruction tympanomastoidectomy.
    Walker PC; Mowry SE; Hansen MR; Gantz BJ
    Otol Neurotol; 2014 Jan; 35(1):e24-30. PubMed ID: 24136324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of hearing after cholesteatoma surgery: the bony obliteration tympanoplasty versus canal wall up and canal wall down without mastoid obliteration.
    van der Toom HFE; van der Schroeff MP; Metselaar M; van Linge A; Vroegop JL; Pauw RJ
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5181-5189. PubMed ID: 35399107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of anterior epitympanic cholesteatoma: expectations after epitympanic approach and canal wall reconstruction.
    Duckert LG; Makielski KH; Helms J
    Otol Neurotol; 2002 Jan; 23(1):8-13. PubMed ID: 11773837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
    Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
    Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mastoid obliteration techniques in cholesteatoma.
    Yung M; Bennett A
    Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.